Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: Preliminary results of a controlled, randomized, regimen-comparative trial
- 1 February 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (2) , S30-S35
- https://doi.org/10.1016/0002-9343(92)90335-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Foscarnet Therapy for Acyclovir-ResistantMucocutaneous Herpes Simplex Virus Infection in 26 AIDS Patients: Preliminary DataThe Journal of Infectious Diseases, 1990
- Foscarnet Therapy for Severe Acyclovir-Resistant Herpes Simplex Virus Type-2 Infections in Patients with the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1989
- Successful Treatment with Foscarnet of an Acyclovir-Resistant Mucocutaneous Infection with Herpes Simplex Virus in a Patient with Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificityAntimicrobial Agents and Chemotherapy, 1987
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982
- ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPYThe Lancet, 1982
- Antiviral effects of phosphonoformate (PFA, foscarnet sodium)Pharmacology & Therapeutics, 1982